期刊文献+

坏死性凋亡的信号转导机制及其在神经外科疾病中的研究进展 被引量:1

Signal transduction mechanisms of necroptosis and relevant advances in neurosurgical diseases research
下载PDF
导出
摘要 坏死性凋亡是指一种以凋亡形式开始的、有坏死表型并被称为程序性坏死或肿瘤坏死因子(TNF)诱导性坏死的一种新的细胞死亡模式。程序性坏死在一些神经外科疾病所引起的神经细胞损伤及死亡中扮演着重要角色,其中包括颅脑外伤、颅内肿瘤和脑血管疾病等。坏死性凋亡信号转导机制的逐渐明晰及高效特异性抑制剂(如necrostatin-1)的发现,为神经外科相关疾病的临床治疗提供新的思路。该文就坏死性凋亡的发现和机制进展进行综述。 Necroptosis is a new mode of cell death that starts with the form of apoptosis, performs as the necrosis-like phenotype, and is known as programmed necrosis or tumor necrosis factor-induced (TNF-induced) necrosis. The programmed necrosis plays an important role in the injury and death of neuronal cell due to some neurosurgical diseases, including craniocerebral trauma, brain tumor, and cerebrovascular diseases. The gradual understanding of signal transduction mechanisms of necroptosis and the discovery of potent specific inhibitors (such as necrostatin-1) provide new ideas for the clinical treatment of neurosurgical diseases. This paper reviews the advances in discovery and mechanisms of necroptosis.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2016年第1期115-118,共4页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家自然科学基金(81171166) 上海市科委基金(11nm0503200)~~
关键词 坏死性凋亡 细胞死亡 信号转导机制 脑卒中 脑外伤 脑肿瘤 necroptosis cell death signal transduction mechanisms stroke traumatic brain injury braintumor
  • 相关文献

参考文献28

  • 1Galluzzi L, Vitale I, Abrams JM, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012[J]. Cell Death Differ, 2011, 19(1): 107- 120.
  • 2Laster SM, Wood JG, Gooding LR. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis[ J]. J Immunol, 1988, 141(8) : 2629 -2634.
  • 3Holler N, Zaru R, Micheau O, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule [ J ]. Nat Immunol, 2000, 1 ( 6 ) : 489 - 495.
  • 4Degterev A, Huang Z, Boyce M, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury[J]. Nat Chem Biol, 2005, 1(2): 112-119.
  • 5Fulda S. The mechanism of neeroptosis in normal and cancer cells [J]. Cancer Biol Ther, 2013, 14(11) : 999-1004.
  • 6Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes [ J ]. Cell, 2003, 114(2): 181 -190.
  • 7Sun L, Wang H, Wang Z, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase [ J ]. Cell, 2012, 148(1 -2) : 213 -227.
  • 8Wang Z, Jiang H, Chen S, et al. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways[J]. Cell, 2012, 148(1 -2) : 228 -243.
  • 9Kaiser W J, Sridharan H, Huang C, et al. Toll-like receptor 3-medi- ated necrosis via TRIF, RIP3 and MLKL[ J]. J Biol Chem, 2013, 288(43) : 31268 -31279.
  • 10Albrecht J, Norenberg MD. Glutamine: a Trojan horse in ammonia neurotoxieity[ J ]. Hepatology, 2006, 44 (4) : 788 - 794.

二级参考文献15

  • 1Abraham MC, Shaham S. Death without caspases, caspases without death(Review). Trends Cell Biol,2004,14 : 184-193.
  • 2Castejon OJ, Arismendi GJ. Nerve cell death types in the edematous human cerebral cortex. J Submicrosc Cytol Pathol, 2006,38 : 21-36.
  • 3Wei L,Ying DJ,Cui L,et al. Necrosis,apoptosis and hybrid death in the cortex and thalamus after barrel cortex ischemia in rats. Brain Res ,2004,1022 ( 1/2 ) : 54-61.
  • 4Degterev A, Huang Z, Boyee M. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol, 2005,1 : 112-119.
  • 5Teng X, Degterev A, Jagtap P, et al. Structure-activity relationship study of novel necroptosis inhibitors. Bioorg Med Chem Lett,2005, 15 : 5039-5044.
  • 6Kawahara M. Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases (Review). J Alzheimers Dis ,2005,8 : 171-182.
  • 7Perl DP, Moalem S. Aluminum and Alzheimer's disease, a personal perspective after 25 years(Review). J Alzheimers Dis, 2006,9 ( 3 Suppl) :291-300.
  • 8Gupta VB, Anitha S, Hegde ML, et al. Aluminium in Alzheimer's disease: are we still at a crossroad(Review) ? Cell Mol Life Sci, 2005,62 : 143-158.
  • 9Zilkova M, Koson P, Zilka N. The hunt for dying neurons: insight into the neuronal loss in Alzheimer's disease(Review). Bratisl Lek Listy,2006,107 (9/10) :366-373.
  • 10Smith CC, Davidson SM, Lim SY, et al. Necrostatin : a potentially novel cardioprotective agent? Cardiovasc Drugs Ther, 2007,21 : 227-233.

共引文献3

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部